A quantitative trait locus (QTL) controlling HbF levels has previously been mapped to chromosome 6q23 in an Asian-Indian kindred with β thalassemia and heterocellular hereditary persistence of fetal hemoglobin (HPFH). Five protein-coding genes, ALDH8A1, HBS1L, cMYB, AHI1 and PDE7B reside in this 1.5Mb candidate interval of 6q23. To direct sequencing efforts we compared the expression profiles of these five genes between 12 individuals with elevated, and 14 individuals with normal HbF levels during adult erythropoiesis by real time quantitative RT-PCR. Two genes, cMYB and HBS1L, demonstrated simultaneous transcriptional down-regulation in individuals with elevated HbF levels. Transfection of K562 cells encoding human cDNA of cMYB and HBS1L genes showed that while over-expression of ectopic cMYB inhibited γ-globin gene expression, overexpression of HBS1L had no effect.
Introduction
Despite their apparent genetic simplicity, it has long been appreciated that both beta thalassemia and sickle cell disease display a remarkable diversity in the severity of their disease. High levels of HbF have been shown to have a beneficial effect in both of these disorders, although the mechanism for the ameliorating effect differs 1 . HbF levels vary considerably not only in patients with these β-globin alleles of the β-globin gene cluster 3 , the genetic etiology of heterocellular HPFH is complex. Twin studies show that 89% of the quantitative variation in HbF and FC levels in normal adults is genetically controlled 4 with 50-60% of the F cell variance due to genetic factors not linked to the β-globin locus 5 . Linkage has been reported between HbF and FC levels and three regions of the genome: on chromosomes Xp22.2-3, 6q23 and 8q [6] [7] [8] . Both the QTLs on chromosome 6q and 8q were reported by our group in an extended Asian Indian family with β thalassemia and heterocellular HPFH. Recently we have conducted a detailed annotation and mutation analysis of all five protein-coding genes in this 6q23 candidate interval, but no causative mutations have been identified in the coding sequence of these genes 9 .
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Materials and Methods

Subjects and analysis of blood samples
Subjects were healthy adults, and consisted of two groups:
1. These 26 adults were unrelated of diverse ethnic backgrounds and do not belong to the Asian Indian kindred 7 . They were healthy adults with no β thalassaemia and were selected on the basis of their HbF levels as measured by high-performance liquid chromatography (HPLC) (BioRad Variant).
Twelve individuals (1 male) had Hb F levels ranging from 0.8% to 1.8% and . Blood samples were collected in EDTA anticoagulant and blood counts were determined using a
Sysmex automated blood cell analyser. F cells were enumerated by flow cytometry of 20,000 cells using anti-γ globin chain antibody conjugated with fluorescein isothiocyanate (FITC) 13 .
The study was approved by the local Ethic Committee (LREC no: 01-332) of King's College Hospital, London.
Cell cultures
Erythroid cells were cultured using a two-phase liquid system (modified from Fibach et al, 1989 11 ). Mononuclear cells were isolated from peripheral blood by centrifugation on a gradient of Ficoll-Hypaque and cultured for 7 days in phase I medium which consist of serum-free StemSpan (Stem Cell Technologies) supplemented with 1 μg/ml cyclosporin A, 25 ng/ml interleukin-3 (IL-3), 50 ng/ml human stem cell factor (Sigma), and 0.01% bovine serum albumin (BSA 
RNA isolation and quantitative real time RT-PCR
Total RNA was isolated using Tri-reagents (Sigma) and quantified by absorbance at 260 nm. cDNA was synthesized using SuperScript III reverse transcriptase (Invitrogen) from 1μg of total RNA. Primers and probes were designed using Primer Express 2.0 program and synthesized by Applied Biosystems. Sequences for primers and probes are available on request. Quantitative RT-PCR was carried out in an ABI 7900 HT Sequence Detection System using TaqMan master mix and the protocol of the manufacturer (Applied Biosystems). All data were normalized using the endogenous HPRT control. Assays for HPRT are available from the Applied Biosystem database. To quantify gene expression, a relative standard method was used. The quantities of targets and of the endogenous HPRT were determined from the appropriate standard curves. The target amount was then divided by the HPRT amount to obtain a normalized value. One of the experimental samples on day 0 (HPRT normalized) was designated as the calibrator, and given a relative value of 1.0.
All quantities (HPRT normalized) were expressed as n-fold relative to the calibrator.
Western blotting
Protein samples were prepared from 2x10 6 Membranes were blocked in Tris-buffered saline (TBS) supplemented with 5% nonfat dry milk powder for 1 hour and incubated overnight with mouse monoclonal antibody against c-MYB (Upstate). Subsequently, the blots were washed three times with TBS-0.05% Tween-20 buffer and reacted with horseradish peroxidase-conjugated rabbit anti-mouse IgG antibody (Dako). The specific proteins were developed using an enhanced chemiluminescent (ECL) detection system (Amersham Biosciences) and exposure to X-ray films. The same blots were stripped by Re-blot Solution (Chemicon Int) and re-labeled with antibodies against β-actin as loading controls. 
Statistical analysis
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Results
Erythroid cell morphology, growth pattern, maturation and frequency of macrophages in heterocellular HPFH vs controls
Cell morphologies exhibit striking changes in the two-phase culture system in cell shape, size, nuclear chromatin and cytoplasmic volume. In phase I, the culture Rapid erythroid expansion was observed in phase II and cell counts were performed on days 0, 2, 3, 4, 5, 6 and 7. An increase in cell number was detected on day 2 with a doubling of the number on day 3, reaching a maximum count on day 6 -day 7, after which the number of cells starts to decline. Throughout phase II, cell count in erythroid cultures of individuals with HPFH was lower than that in the controls ( Figure 1A ).
Differentiation of the erythroid progenitors in phase II was monitored using two surface membrane proteins, transferrin receptor (CD71) and glycophorin A (GPA). CD71 is expressed on all proliferating hematopoietic cells and although it is not erythroid lineage specific, it is highly expressed in early erythroid progenitors.
GPA on the other hand is erythroid lineage-specific and initially expressed when CD34 is downregulated. GPA expression represents the later stages of erythroid differentiation compared to CD71. On day 2 of phase II, we observed that 10-40% of the cells highly expressed CD71 with 2-10% cells expressing GPA. As cells proliferated and differentiated, the percentages of cells simultaneously expressing CD71 and GPA increased rapidly. Initially CD71 high expression shifted to CD71 med expression. On day 5, a small proportion of erythroid cells was enucleated but was not observed to increase on days 6 and 7, the implication being that enucleated erythrocytes undergo apoptosis, as they are not stable in these culture conditions. On We observed different frequencies of macrophages in the erythroid cell cultures between the two groups. Cytospin slides were prepared from all samples on day 5 of phase II. Wright-Giemsa-stained cytospins were examined under a microscope and a total of 400 cells counted. HPFH erythroid cell cultures showed relatively more macrophages compared to controls (mean of 7.85% of total cells in HPFH vs. 1.57% in controls), the difference was statistically significant (p= 0.0127, Figures 1C and 1D ).
Characteristics of globin gene expression by quantitative real-time RT-PCR
In both groups the relative mRNA transcripts of α-, β-and γ-globin all increased during the secondary culture after EPO supplement (Figure 2A ). α-and β-globin transcripts increased dramatically and their levels were much higher than those of γ-globin transcripts. γ-globin expression increased by an average of 4-5 fold on day 7, compared to an increase of 17-20 fold for α-, and 9-11 fold for β-globin. As erythropoiesis matures, the ratio of γ-to β-globin transcripts decreased ( Figure 2B ), reflecting the fall in the levels of HbF (α2γ2) as adult erythropoiesis advanced. The average levels for the expressions of the globin genes were generally higher for the HPFH group when compared to control throughout the secondary culture, which is in agreement with the accelerated erythroid maturation observed. The average γ/β globin transcript ratios were also higher in the heterocellular HPFH group throughout phase II, the highest ratios being observed at the early stage of erythropoiesis in both groups ( Figure 2B ).
Differential expression of the genes in the 6q23 candidate interval by quantitative real-time RT-PCR
The candidate interval of 1.5 Mb in chromosome 6q23.2 contains five proteincoding genes, ALDH8A, HBS1L, cMYB, AHI1 and PDE7B which we tested.
ALDH8A1 expression was low on day 0 (Ct values around 33 -36 cycles), which was further downregulated during the secondary culture. There was no significant difference in ALDH8A1 expression between the two groups ( Figure 3A ). AHI1 has relatively high expression in hematopoietic progenitors on day 0 of phase II in both groups (Ct values around 28-30 cycles), but downregulated to similar levels of
throughout phase II. Again, there was no significant difference in the levels of AHI1 transcripts between the two groups ( Figure 3A ). PDE7B expression was detected at very low levels on day 0 (Ct values around 33-37 cycles), and hardly detectable from day 3 to day 7 of phase II, an indication that PDE7B is not expressed in the erythroid lineage ( Figure 3A) .
The mean levels of HBS1L mRNA transcripts detected in the HPFH group were significantly lower compared to control throughout phase II (p values = 0.0088, 0.0065, 0.0025 on days 0, 3, 5 respectively, Figure 3A) . Similarly, the mean values of cMYB gene expressions were significantly lower in the HPFH group compared to those in the control group (p=0.0082 and <0.0001 on days 3 and 5 respectively, Figure 3A) . No difference was detected in the levels of cMYB expression between the male and female individuals within our control group.
The cMYB protein (75 kD) has an isoform of 89 kD (cMYB-9A) caused by a splice variant which leads to an insertion of 363 bp between exon 9 and 10 (exon 9A) 14, 15 . Using primer and probes specific for cMYB-9A, we confirmed that the pattern of cMYB-9A expression was similar to that of the total cMYB transcript, ie. lower in the HPFH group when compared to control. The differences in mean values between these two groups were statistically significant on days 0 and 3 (p= 0.0194 and 0.0310 on days 0 and 3, respectively, Figure 3A) . Furthermore, the expression levels of cMYB and cMYB-9A were highly correlated (Pearson correlation coefficient r=0.95, Figure 3B ). Both HBS1L and cMYB expression increased on day 3 of phase II when compared to day 0, followed by a decline on day 5 and in both cases, the expression was lower in the HPFH group when compared to control. Analysis of more than a hundred erythroid cell samples at different stages of phase II showed that the levels of Figure 3C) 4. Overexpression of cMYB inhibited the expression of γ-globin in K562 cells, but overexpression of ectopic HBS1L had no effect on γ-globin expression In order to determine whether cMYB or HBS1L, or both, are involved in the regulation of γ-globin gene expression, we stably transfected cMYB and HBS1L into K562 cells, and analyzed multiple cMYB-expressing, HBS1L-expressing and vectoralone transfected clones. Both cMYB and HBS1L transfected clones expressed far more mRNA transcripts above the endogenous background levels as expected ( Figure   4A ). Furthermore, cMYB expressing clones inhibited γ-globin gene expression when compared with the parental cell line (p=0.013) or vector controls (p=0.017, Figure   4B ). However, HBS1L had no effect on γ-globin gene expression although the clones expressed 2-8 fold of HBS1L mRNA transcripts above the background ( Figure 4B ).
While cMYB and γ-globin mRNA levels were significantly inversely correlated (correlation coefficient = -0.61, p=0.009, Figure 4C ), there was no correlation between HBS1L and γ-globin mRNA levels ( Figure 4C ).
Discussion
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We have previously mapped a QTL for heterocellular HPFH on chromosome 6q23 7, 16 , but analysis of the coding sequence of the genes in the region did not reveal any causative mutation in a panel of subjects 9 . Using a two-phase liquid erythroid culture system (modified from 11 ), we have observed that two -cMYB and HBS1L -of the five protein-coding genes in the candidate region, showed significant alterations in their expression profiles in individuals with heterocellular HPFH when compared to controls. The data suggest that a high HbF phenotype is associated with lower cMYB levels in erythroid cultures.
We observed other phenotypes that were consistent with the lower cMYB expression. For example, erythroid cell cultures of HPFH individuals showed relatively higher number of macrophages when compared to controls, a feature consistent with that noted in a mouse cMYB knockdown study in which low levels of cMYB favored differentiation of macrophage and megakaryocytes, with perturbed erythroid differentiation 17 . cMYB knockout mice die in utero due to a block in erythropoiesis. Apart from primitive erythrocytes, the only mature cells present in the cMYB -/-fetal livers were megakaryocytes and macrophages 18 . Further, mice bearing a hypomorphic allele of cMYB induced by N-ethyl-N-nitrosourea (ENU) mutagenesis had a myeloproliferative syndrome with supraphysiological expansion of megakaryocyte and platelet production, and anemia 19, 20 . In keeping with these observations, we noted that although both the HPFH and control groups have platelet levels within the normal range, HPFH individuals who had lower cMYB expression, had relatively higher platelet counts. There was a trend towards a positive correlation between the platelet counts and F cell percentages in this group of 26 subjects athough the results were not significant ( Figure 5A ).
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From Our data and others' [21] [22] [23] [24] indicate that hemoglobin switching is likely to be cell cycle related and linked to differentiation events as summarized in a recent review on the regulation of HbF production in adult erythropoiesis 25 . As differentiation advances, a change in globin gene transcription program occurs, from a program of predominant γ globin expression to one that supports mainly β globin expression.
Although the molecular mechanism is not evident, our observations suggest that Various studies deduced that cMYB blocks differentiation by maintaining proliferation but cMYB has also been shown to inhibit terminal erythroid differentiation 26 . Analysis of knock-down mice/embryos suggested that erythroid development is very sensitive to changes in cMYB levels and that there may be a differential requirement for cMYB in the proliferation of early and late progenitors 26 .
It would appear that in adults with normal levels of HbF, the levels of cMYB support a balance of proliferation and differentiation such that the majority of erythroid cells mature to erythroblasts that mainly synthesize adult hemoglobin. Few progenitor cells terminate prematurely before the change in program takes place. In HPFH individuals with their relatively lower levels of cMYB expression, more of the progenitors and erythroblasts terminate prematurely during the proliferation cycles of adult erythropoiesis, producing more erythroid cells that synthesize predominantly HbF.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From Thus in the presence of lower cMYB levels, we would predict a relatively lower erythrocyte count in HPFH individuals, resulting from the reduced number of proliferation cycles and accelerated erythroid maturation, in combination with higher HbF and F cell levels. Indeed, analysis of 850 healthy adult females showed that F cell percentages are inversely correlated with the erythrocyte counts. Individuals with higher F cell percentages tend to have lower erythrocyte counts (p=0.004, Figure 5B ). Further, individuals with higher F cell percentages also tend to have higher mean cell volumes (MCV) indicating a younger erythrocyte population ( Figure 5C ).
It is evident from several studies that multiple intracellular signaling pathways are involved in the control of globin gene transcription and cMYB is critical for erythroid development 26 , 27, 28 . The conditions of human erythroid culture could be manipulated to produce low or high fetal hemoglobin production; CD34 cells cultured in EPO alone was associated with low HbF production, while CD34 cells cultured in EPO, SCF and TGF-β was associated with high HbF production 29 . In addition, a correlation between cMYB expression patterns and HbF could be demonstrated under these manipulated in-vitro conditions 30 . It would appear that cMYB expression is affected by these growth factors that are involved in intracellular signal transduction.
The cMYB protein could thus be a downstream effector of the various genes controlling HbF levels.
Equally, cMYB may act more upstream regulating the activity and expression of other proteins that are involved in various stages of hematopoiesis. The cMYB protein may directly activate the transcription of one of these genes, or the action may be more indirect, through a gene activated within the cMYB transcriptional cascade.
Cyclin A1, c-kit, bcl-2, mim-1 have been demonstrated to be direct cMYB target 31 , and many others have been shown to be regulated by cMYB protein 28, 32, 33 .
They are mainly involved in signal transduction and regulatory decisions affecting cell proliferation, differentiation and apoptosis. Recent studies confirmed that cMYB is strictly required for the expression of c-kit receptor 26 , which interacts with SCF, EPO receptor and EPO in the development of the erythroid program 34, 35 . The cMYB transcription factor also interacts with a large collection of co-factors in different ways, leading to the regulation of different sets of targets. CBP or CREB-binding protein and p300 are ubiquitous co-activators that also interact with cMYB 36, 37 . These have histone acetyltransferase activity, and presumably play a role in chromatin remodeling.
Thus, it is important to note that our data does not necessarily implicate the cMYB locus as the QTL or the only QTL underlying the high HbF phenotype in the individuals in this study. Heterocellular HPFH is genetically heterogeneous with several loci contributing to the high HbF phenotype 5, 38 . What our experiments have shown is that cMYB expression in healthy adults is variable, and that lower cMYB expression is associated with higher HbF levels. It is likely that cMYB is a quantitative trait gene and that levels of the cMYB product are controlled by cisregulatory and trans-acting factors 39 .
But, whilst we make no assumptions concerning the gene responsible for the high F phenotype in the individuals in this study, among the panel of protein-coding genes within the chromosome 6q23 interval, cMYB must be the prime candidate in the Asian Indian family 16 . The role of cMYB in accelerating erythroid maturation could explain the disproportionately higher HbF levels in subjects with β thalassemia in the Asian Indian family in which the 6q QTL is a major determinant of the HbF levels 7, 40 . In this kindred, among individuals possessing the 6q genotype, those without β thalassemia had elevated HbF levels of up to 2.4%, while those who are heterozygous for β thalassemia had HbF levels ranging from 3.0% in those with a single copy of the 6q genotype, to 24% in those with two copies. The proband who was homozygous for β thalassemia and heterozygous for the 6q genotype, was transfusion independent with hemoglobin levels of 11-12 g/dL, all of which was HbF 40, 41 . It would appear that the lower cMYB expression implicated from the 6q genotype, together with the rapid erythroid regeneration under the 'stressed erythropoiesis' further increases the proportion of early erythroid progenitors that still possess the primitive fetal globin program, leading to the unusually high fetal hemoglobin levels in those with β thalassemia.
Although cMYB is a prime candidate underlying the high HbF phenotype in the Asian Indian family, identification of the causative sequence variant(s) could be a daunting challenge. To date, the regulatory sequences controlling cMYB expression are still not completely clear. Our expression profile studies suggest that cMYB may be co-regulated with HBS1L. Interestingly, other studies on pancreatic cancer tissues and cell lines using comparative genomic hybridization showed that when cMYB proto-oncogene was overexpressed, HBS1L seemed to be coamplified with cMYB as well 42 . 
